The Santaniello theorem of irreversible benefits by Wesseler, Justus
MPRA
Munich Personal RePEc Archive
The Santaniello theorem of irreversible
benefits
Justus Wesseler
Wageningen University
January 2009
Online at http://mpra.ub.uni-muenchen.de/25602/
MPRA Paper No. 25602, posted 8. September 2011 13:45 UTC
The Santaniello Theorem of Irreversible Benefits 
 
Justus Wesseler1 
 
1Environmental Economics and Natural Resources Group, Wageningen University, 
The Netherlands, e-mail: justus.wesseler@wur.nl 
 
 
 
 
 
 
 
 
Copyright 2008 by Justus Wesseler. All rights reserved. Readers may make verbatim 
copies of this document for non-commercial purposes by any means, provided that 
this copyright notice appears on all such copies. 
The Santaniello Theorem of Irreversible Benefits 
 
Justus Wesseler 
 
Wageningen University, The Netherlands 
 
Abstract 
 
Irreversible benefits do favor an earlier introduction of GM crops versus a later one. A 
non-trivial question is if they also do weigh more than reversible benefits similar to 
irreversible costs but in the opposite direction. 
 
In this contribution I will show that indeed irreversible benefits do weigh more than 
reversible once and indeed do result in an irreversibility effect, albeit a positive one. 
The problem can be summarized by the following theorem: 
 
Irreversible benefits do justify the immediate introduction of transgenic crops, even if 
future uncertainty about reversible benefits include negative benefits and traditional 
cost-benefit-analysis treating all benefits and costs as reversible would reject the 
introduction. 
 
This theorem I call in honor of Vittorio Santaniello the “The Santaniello Theorem of 
Irreversible Benefits.” 
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The International Consortium on Agricultural Biotechnology Research (ICABR) 
holds annual meetings since 1997. Vittorio Santaniello was one of the founding 
fathers and main organizers of the conference (Pray et al., This Journal). He has been 
a strong supporter of agricultural biotechnologies, but was also aware and concerned 
about the social and political issues surrounding the technology (Santaniello, 2005). 
He in particular emphasized the irreversible benefits the technology provides in 
debates with people concerned about the irreversible costs of the technology. 
 
Irreversible costs and their relevance for decision making, in general, is by now well 
known within the economic literature. The first authors explicitly mention that 
irreversible costs do matter differently than reversible costs for decision making are 
Arrow and Fisher (1974), introducing the concept of quasi-option value, and Henry 
(1974) introducing the irreversibility effect. The financial economics literature did 
provide the foundations for the real option value theory by presenting an approach 
that allows to derive the “fair price” for a call option (Black and Scholes, 1973, 
Merton, 1973).1 The first application of the concept of valuing real investments using 
financial option models can be traced back to Myers (1977). While there are some 
subtle differences between the three concepts, the overall result - the possibility of 
postponing a decision including irreversible costs has an extra value that needs to be 
considered - holds for all three concepts. This extra value is present in all three 
approaches as over time additional information will become available and can be used 
by the decisions maker to up-date the expected benefits and costs and allows to 
reconsider previous decisions. It is a form of Bayesian learning with explicit 
consideration of time. 
 
The concepts of quasi-option values, irreversibility effects, and real-option values 
have been applied to a number of problems. Merton (1998), Trigeorgis (1995), and 
Dixit and Pindyck (1994) provide an overview about the methods and their 
applications. Applications to issues surrounding transgenic crops include Beckmann 
et al. (2006), Demont et al. (2004, 2005), Knudson and Scandizzo (2000, 2001, 2002, 
2006), Morel et al. (2003), Soregaroli and Wesseler (2005), Weaver and Wesseler 
                                                 
1 An investment can be seen similar to a call option while the holder of the call has the right but not the 
obligation to exercise the call and receives if the call will be exercised in return a stock, the investor 
has the right but not the obligation to invest and receives against the payment of the investment the 
benefit stream generated by the investment. As it is not always optimal from an economic point of view 
to exercise a call option immediately even if the call option is “in the money”, it is not optimal to invest 
immediately even if the expect benefit stream exceeds the investment costs. 
(2004, 2006), Wesseler et al. (2007). Most of the applications have first been 
presented at one of the ICABR meetings. 
 
 
The “Santaniello Theorem of Irreversible Benefits” 
 
Vittorio Santaniello early on has pointed out that not only irreversible costs of the GM 
crop technology should be considered but irreversible benefits as well. This argument 
is less trivial than it seems for two reasons. First, obvious to many economists 
irreversible benefits do favor an earlier introduction of GM crops versus a later one, 
but this has been largely neglected within empirical studies on consumer attitudes 
towards GMOs. Second, less obvious is if irreversible benefits also do weigh more 
than reversible benefits similar to irreversible costs but in the opposite direction and 
by this introduce an asymmetry similar to the one of irreversible costs. 
 
The importance of Vittorio Santaniello’s comment can be stated in the following way: 
 
“Irreversible benefits do justify the immediate introduction of transgenic crops, even 
if future uncertainty about reversible benefits include negative benefits and traditional 
cost-benefit-analysis treating all benefits and costs as reversible would reject the 
introduction.” 
 
In honor of Vittorio Santaniello for his contribution to the economics and policy of 
agricultural biotechnology I call this the “Santaniello Theorem of Irreversible 
Benefits”. 
 
The proof of the theorem can be found in the appendix.  
 
 
Interpretation of the theorem 
 
A numerical example may help to appreciate the implications of the theorem. 
Choosing a discount rate r of 10%, NB0 = 100, NB1h = 10, NB1l = -200, and q = 1-q = 
0.5 we get for B following equation 2 in the appendix: 
 
20 200100 0.5 0.5 800
0.1 0.1
B         
 
Following equation 4 in the appendix results in 
 
20100 0.5 200.
0.1
B       
 
As the numerical example illustrates there is a difference in necessary irreversible 
benefits of 1000 units depending on the valuation approach being used. Applying the 
“Santaniello Theorem of Irreversible Benefits” the mere presence of positive 
irreversible benefits would in this case justify an immediate introduction, while 
following the standard benefit-costs-analysis the irreversible benefits have to be at 
least 800 units. As can be easily seen, even negative annual incremental reversible 
benefits can be tolerated in the presence of irreversible benefits.  
 
The difference in the results with and without considering the irreversible benefits 
effect can be explained in the different treatment of future information. In the first 
case, the standard benefit-costs-analysis, future negative reversible net-benefits, 
 1 0lNB  , still enter the valuation. In the second case, the arrival of future 
information is considered and in the case  1 0lNB   GM crops will be disadopted and 
do enter the valuation with zero value.  
 
While in the first case a value of B > 800 would support immediate introduction and 
support the argument for subsidizing the technology in the second case considering 
the irreversible benefit effect for the same amount of irreversible benefits a much 
higher subsidy can be justified.2 
 
The simple model presented in the appendix is sufficient for proving the irreversible 
benefit effects while a number of modifications are possible. This includes 
considering irreversible costs, uncertainty about irreversible benefits and costs, 
irreversible benefits and costs of changing from adoption to disadoption of the GM 
crop, decrease of incremental reversible benefits and more (e.g. Demont et al., 2005; 
Henessy and Moschini, 2005). 
 
 
Evidence and Implications of Irreversible Benefits 
 
The empirical evidence for irreversible benefits in the European Union is weak. The 
studies for Europe only indicate small amounts of irreversible benefits, which can be 
mainly explained by the low use of insecticides to control the European Corn Borer 
and the relatively low use of herbicides in sugar beets and corn and ban of a number 
of harmful pesticides. Demont et al. (2004) calculated irreversible benefits for 
herbicide tolerant sugar beets to be about 1.60€ per hectare and year while Wesseler 
et al. (2007) calculated irreversible benefits of about 0.81 to 1.08 € per hectare for Bt 
                                                 
2 A cautious note is warranted for not getting misunderstood about the subsidy argument. The subsidy 
argument relates to supporting the introduction of GM crops through providing the appropriate 
infrastructure such as a seed distribution system. At farm level the technology has to pay to provide 
sufficient incentives for farmers using the technology. 
corn and 1.69 to 2.62 € per hectare for herbicide tolerant crops in selected EU 
member states. 
 
Vittorio Santaniello was more concerned about the irreversible benefits the 
introduction of GM crops will generate for developing countries in particular by the 
positive effect on malnourishment and farmers’ health (Santaniello 2002, 2005). 
Malnourishment of young children for more than two years can result in stunted 
growth negatively affecting future mental capabilities. This effect is irreversible and 
can even be passed down to the next generation. Reducing malnourishment can 
amount to a considerable irreversible benefit effect acknowledging at least 400 
million and more likely 600 million undernourished people in the world around 2015 
(FAO, 2004). The “Santaniello Theorem of Irreversible Benefits” indicates that 
perhaps much more can be gained by the introduction of GM crops in developing 
countries than reported by most current studies. 
 
Another example is the control of “black Sigatoka” in bananas in places where they 
are a staple crop such as Uganda. Concerns about the irreversible costs of introducing 
GM banana cost the economy of Uganda range from about 180 to 365 million USD a 
year (Kikulwe et al., 2008). The results presented by Kikulwe et al. (2009) show the 
delayed introduction in particular harms less wealthier households in rural areas as 
they express the highest willingness-to-pay for the technology. 
 
Research on HIV/AIDS in Africa shows the number and quantity of crops grown in 
the home garden increases among HIV/AIDS affected households (Gebreselassie, 
2009). This opens-up the possibility for HIV/AIDS mitigation through improved 
nutritional value via biofortification of home garden crops. Irreversible health benefits 
can be gained by Bt-corn with lower levels of mycotoxins (Wu, 2006). The research 
on pesticide use in Bt cotton (Kuosmanen et al., 2006; Huang et al., 2002; Pray et al., 
2001) and insect-resistant rice in China (Huang et al., 2005, 2007) show a huge 
decrease in pesticide use. The pesticide use among Bt cotton farmers decreased by 
about 58% as reported by Huang et al. (2002) and among rice farmers by about 80% 
as reported by Huang et al. (2005).  
 
While the assessment of productivity and health affects of GM crops is more complex 
than illustrated by the numbers being presented (Scatasta and Wesseler, 2004; Waibel 
et al., 2003) the positive irreversible health effects can hardly be denied. 
 
 
Skepticism Towards Considering Irreversibilities 
 
Many colleagues have been skeptical about using a real option approach for analyzing 
the irreversible benefits and costs of GM crops. The standard criticisms are “there are 
no irreversible costs”, the approach is “complicated” and “uses many assumptions”.  
 
The “there are no irreversible costs” argument misses the point that more than half of 
the population all over the world shows reservations towards the technology, because 
of subjectively perceived irreversibilities. Ignoring those concerns does not help to 
increase trust in the economic analysis of costs and benefits of the technology.  
 
In particular in the European Union concerns about irreversible environmental effects 
of GM crops have been put forward as an argument for postponing the introduction 
(Commission of the European Communities, 1999). Actually, if there were no 
concerns about irreversible effects, there would nothing be against an immediate 
introduction. This holds even under uncertainty, as benefits and costs are supposed to 
be reversible and if the future turns out to be not as favorable as expected growing of 
the GM crop could be stopped without any additional costs after. As Paarlberg (2008) 
in his seminal contribution has shown those concerns are also important for decision 
makers in Africa. 
 
Research explicitly considering potential irreversible costs (Demont et al., 2004; 
Scatasta et al., 2006; Wesseler et al., 2007) actually casts doubts about irreversible 
costs as being sufficiently large to postpone immediate introduction of herbicide 
tolerant sugar beets, herbicide tolerant corn, and Bt-corn in the EU. The result of the 
case study from Portugal (Skevas et al., this journal) actually indicates the reversible 
incremental benefits for Portugal being even larger than predicted in Wesseler et al. 
(2007). 
 
The “complicated” argument reflects a misunderstanding about the approach being 
used. The different specifications of real option models almost all try to investigate 
the value of a technology under uncertainty. The irreversibility effect often enters the 
analysis very much in a standard fashion by calculating the value of a call option with 
an uncertain underlying asset, the GM crop. The valuation of the GM crop is 
complicated and by this the real option value. But the value of the GM crops will be 
needed whether or not the real option value or a different valuationapproach will be 
used.  
 
The same holds for the widely shared view the real option approach “uses many 
assumptions”. This view misses the point that having made one assumption is not 
having made a different one. By this, rejecting an approach by the number of 
assumptions is an empty argument. The more relevant question is whether or not the 
assumptions being made are reasonable. Space does not allow to discuss this in detail 
and I refer the interested reader to the book by Shreve (2005) discussing all the details 
of the approach. At least, the assumptions and the approach in general seems to be 
convincing to many economists. The “founding fathers” have been awarded with the 
Noble prize in economics for the call option pricing formula (Robert C. Merton and 
Myron S. Scholes in 1997) and for pricing assets under uncertainty (Harry M. 
Markowitz, Merton H. Miller, William F. Sharpe in 1990) as well as the AERE 
Publications of Enduring Quality Award for decision making under uncertainty and 
irreversibility (Kenneth Arrow and Anthony C. Fisher in 1995).  
 
Concluding 
 
Vittorio Santaniello has been one of the few colleagues I met who immediately 
understood the relevance and implications of irreversible benefits and costs within the 
debate about the economics and politics of GM crops. By stressing the irreversible 
benefits Vittorio Santaniello has always reminded us and in particular those 
concerned about the technology, those irreversible benefits and costs are the two sides 
of the same coin. 
 
The ICABR meetings have always been a place where different scholars have 
presented work including irreversibilities including, just to name a few Volker 
Beckmann, Matty Demont, Joze Falck-Zepeda, Richard Gray, Enoch Kikulwe, Odin 
Knutsen, Pasquale Scandizzo, Sara Scatasta, Claudio Soregaroli, Robert D. Weaver, 
David Zilberman and myself. The presentations always have resulted in a lively 
debate. By this, Vittorio Santaniello has contributed another irreversible benefit. 
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Appendix 
 
Proof: For proofing the theorem consider a two period model with t0 indicating the 
present and t1,…,∞ indicating the future, one and more years from now. The annual 
incremental reversible net-benefits of introducing a new GM crop will be denoted by 
NBt. NB0 is known but NBt>0 is uncertain. For simplifying the proof uncertainty will 
be fully resolved at an infinitesimal time step before t1. At t1 NB1 can reach two states 
of nature, either NB0 has changed with probability q to NB1h or with probability (1-q) 
to NB1l. For avoiding triviality assume NB1l < 0. The appropriate discount rate will be 
denoted by r. The objective of the decision maker is to maximize the total benefit of 
introducing the GM crop. 
 
The strategy is to first develop the decision criterion ignoring the irreversibility effect 
of irreversible benefits and than to compare the result with the one including the 
effect. 
 
The total incremental reversible net-benefits of introducing the new GM crop at farm 
level will be  
 
 1 10 1
h lNB NBNB q q
r r
    
and by considering external constant irreversible benefits B immediate introduction 
would be justified if 
 
 1 10 1 0
h lNB NBB NB q q
r r
      (1) 
or the decision will be choosing 
 
 1 10max 1 ,0
h lNB NBB NB q q
r r
      
 (2) 
 
Here, we can already observe, irreversible benefits do have a positive affect and 
increase the likelihood of introduction in comparison to the situation where they are 
not present. But what is also obvious, they have the same affect as an increase in NB0. 
 
The value of introducing the new GM crop one year from now considering using 
additional information, assuming 11 0
l
l NBB NB
r
     
, again to avoid triviality, and 
considering that growing the GM crop is reversible: 
 
1
1max ,0
h
h NBq B NB
r
         
 at t=1. (3) 
From this directly follows the value of introducing the GM crop immediately 
considering the arrival of future information with NB0 > 0: 
 
1
0max ,0
hNBB NB q
r
    
 (4) 
 
Comparing equation 2 and equation 4 we immediately observe for 1 0 :
lNB   
 
 1 1 11h h lNB NB NBq q q
r r r
   ▄ (5) 
 
The “Santaniello Theorem of Irreversible Benefits” implies an irreversibility effect in 
a two states two times model of   11 lNBq
r
 . By this factor necessary irreversible 
benefits can be smaller in comparison to an approach that does not consider the arrival 
of future information. Following standard dynamic optimization procedures moving 
from discrete time to continuous time and assuming future incremental reversible 
benefits following a binomial distribution converging to continuous state under 
infinity provides the following result for irreversible benefits: 
 
2
* 0
1 2 2 2
1
1 1 2, with 
2 2
1 1
NB r r rB      

        

 
 
assuming appropriate boundary conditions, where 1 is the solution of a second order 
homogeneous equation, δ the convenience yield and σ the variance rate of a geometric 
Brownian motion. For the details see, e,g., Dixit and Pindyck (1994) or McDonald 
and Siegel (1986). 
 
 
